Tonix Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Highlights
GlobeNewswire
On track to submit NDA in the second half of 2024 for Tonmya™ for fibromyalgia; pre-NDA meeting with FDA scheduled for second..
On track to submit NDA in the second half of 2024 for Tonmya™ for fibromyalgia; pre-NDA meeting with FDA scheduled for second..
Senegalese leader, Bassirou Diomaye Faye, on March 25, with sincerity, made an unexpected committment to tackle deep-seated..
Sarge opens the show by playing one of Dr. Peter Glidden's fantastic webinars on Bone and Joint Health! It compares and..